These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
300 related articles for article (PubMed ID: 23211054)
21. Evaluation of progression markers in the premotor phase of Parkinson's disease: the progression markers in the premotor phase study. Liepelt-Scarfone I; Gauss K; Maetzler W; Müller K; Bormann C; Fruhmann Berger M; Timmers M; Streffer J; Berg D Neuroepidemiology; 2013; 41(3-4):174-82. PubMed ID: 24051361 [TBL] [Abstract][Full Text] [Related]
22. When does Parkinson's disease begin? Gaig C; Tolosa E Mov Disord; 2009; 24 Suppl 2():S656-64. PubMed ID: 19877243 [TBL] [Abstract][Full Text] [Related]
23. Biomarkers of Parkinson's Disease: An Introduction. Titova N; Qamar MA; Chaudhuri KR Int Rev Neurobiol; 2017; 132():183-196. PubMed ID: 28554407 [TBL] [Abstract][Full Text] [Related]
25. Biomarkers for the diagnosis and management of Parkinson's disease. Waragai M; Sekiyama K; Fujita M; Tokuda T; Hashimoto M Expert Opin Med Diagn; 2013 Jan; 7(1):71-83. PubMed ID: 23530844 [TBL] [Abstract][Full Text] [Related]
26. Biomarkers in Parkinson's disease: Advances and strategies. Delenclos M; Jones DR; McLean PJ; Uitti RJ Parkinsonism Relat Disord; 2016 Jan; 22 Suppl 1(Suppl 1):S106-10. PubMed ID: 26439946 [TBL] [Abstract][Full Text] [Related]
27. Biomarkers of Parkinson's disease and Dementia with Lewy bodies. Henchcliffe C; Dodel R; Beal MF Prog Neurobiol; 2011 Dec; 95(4):601-13. PubMed ID: 21983334 [TBL] [Abstract][Full Text] [Related]
28. [Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease]. Hattori N Rinsho Shinkeigaku; 2004; 44(4-5):241-62. PubMed ID: 15287506 [TBL] [Abstract][Full Text] [Related]
29. Biological confounders for the values of cerebrospinal fluid proteins in Parkinson's disease and related disorders. Mollenhauer B; Parnetti L; Rektorova I; Kramberger MG; Pikkarainen M; Schulz-Schaeffer WJ; Aarsland D; Svenningsson P; Farotti L; Verbeek MM; Schlossmacher MG J Neurochem; 2016 Oct; 139 Suppl 1():290-317. PubMed ID: 26452984 [TBL] [Abstract][Full Text] [Related]
30. The Role of Salivary Biomarkers in the Early Diagnosis of Alzheimer's Disease and Parkinson's Disease. Pawlik P; Błochowiak K Diagnostics (Basel); 2021 Feb; 11(2):. PubMed ID: 33671562 [TBL] [Abstract][Full Text] [Related]
31. The Concept of Prodromal Parkinson's Disease. Mahlknecht P; Seppi K; Poewe W J Parkinsons Dis; 2015; 5(4):681-97. PubMed ID: 26485429 [TBL] [Abstract][Full Text] [Related]
32. Imaging Markers of Progression in Parkinson's Disease. Strafella AP; Bohnen NI; Pavese N; Vaillancourt DE; van Eimeren T; Politis M; Tessitore A; Ghadery C; Lewis S; Mov Disord Clin Pract; 2018; 5(6):586-596. PubMed ID: 30637278 [TBL] [Abstract][Full Text] [Related]
33. In search of Parkinson's disease biomarkers - is the answer in our mouths? A systematic review of the literature on salivary biomarkers of Parkinson's disease. Figura M; Friedman A Neurol Neurochir Pol; 2020; 54(1):14-20. PubMed ID: 32003440 [TBL] [Abstract][Full Text] [Related]
34. Emerging role of S100B protein implication in Parkinson's disease pathogenesis. Angelopoulou E; Paudel YN; Piperi C Cell Mol Life Sci; 2021 Feb; 78(4):1445-1453. PubMed ID: 33052436 [TBL] [Abstract][Full Text] [Related]
35. Cerebrospinal Fluid Biomarkers for Target Engagement and Efficacy in Clinical Trials for Alzheimer's and Parkinson's Diseases. Parnetti L; Eusebi P; Lleó A Front Neurol Neurosci; 2016; 39():117-23. PubMed ID: 27463974 [TBL] [Abstract][Full Text] [Related]
36. Current advances in metabolomic studies on non-motor psychiatric manifestations of Parkinson's disease (Review). Ciobanu AM; Ionita I; Buleandra M; David IG; Popa DE; Ciucu AA; Budisteanu M Exp Ther Med; 2021 Sep; 22(3):1010. PubMed ID: 34345292 [TBL] [Abstract][Full Text] [Related]